A prospective case–control study reported a positive association between insulin and early gastric cancer risk [40] but did not analyze by cancer subtype; although a nested case–control study showed a positive association between both C-peptide and insulin for NCGC but the risk estimates were not significant [10]. The gene discussed is INS; the disease is gastric cancer.